Cargando…
Risk factors and 26-years worldwide prevalence of endoscopic erosive esophagitis from 1997 to 2022: a meta-analysis
Erosive esophagitis (EE) is the part of gastroesophageal reflux disease (GERD) spectrum and may progress to esophageal adenocarcinoma. Due to its progressivity and unclear prevalence, we aim to identify the factors contributing in EE to decide the need for further examination. We performed a PRISMA...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502104/ https://www.ncbi.nlm.nih.gov/pubmed/37709957 http://dx.doi.org/10.1038/s41598-023-42636-7 |
_version_ | 1785106247950794752 |
---|---|
author | Witarto, Andro Pramana Witarto, Bendix Samarta Pramudito, Shidi Laras Ratri, Lintang Cahyaning Wairooy, Nabilah Azzah Putri Konstantin, Tiffany Putra, Achmad Januar Er Wungu, Citrawati Dyah Kencono Mufida, Annisa Zahra Gusnanto, Arief |
author_facet | Witarto, Andro Pramana Witarto, Bendix Samarta Pramudito, Shidi Laras Ratri, Lintang Cahyaning Wairooy, Nabilah Azzah Putri Konstantin, Tiffany Putra, Achmad Januar Er Wungu, Citrawati Dyah Kencono Mufida, Annisa Zahra Gusnanto, Arief |
author_sort | Witarto, Andro Pramana |
collection | PubMed |
description | Erosive esophagitis (EE) is the part of gastroesophageal reflux disease (GERD) spectrum and may progress to esophageal adenocarcinoma. Due to its progressivity and unclear prevalence, we aim to identify the factors contributing in EE to decide the need for further examination. We performed a PRISMA 2020-based systematic search through PubMed and other resources up to June 2, 2022. Study quality was assessed using the Newcastle–Ottawa Scale (NOS). The odds ratio (OR) of each factor and worldwide prevalence of EE were measured. There are 114 observational studies included with a total of 759,100 participants. Out of 29 factors, the significant risk factors are age ≥ 60 y.o. (OR 2.03 [1.81–2.28]), White/Caucasian (OR 1.67 [1.40–1.99]), unmarried (OR 1.08 [1.03–1.14]), having GERD ≥ 5 years (OR 1.27 [1.14–1.42]), general obesity (OR 1.78 [1.61–1.98]), central obesity (OR 1.29 [1.18–1.42]), diabetes mellitus (DM) (OR 1.24 [1.17–1.32]), hypertension (OR 1.16 [1.09–1.23]), dyslipidemia (OR 1.15 [1.06–1.24]), hypertriglyceridemia (OR 1.42 [1.29–1.57]), hiatal hernia (HH) (OR 4.07 [3.21–5.17]), and non-alcoholic fatty liver disease (NAFLD) (OR 1.26 [1.18–1.34]). However, H. pylori infection (OR 0.56 [0.48–0.66]) and atrophic gastritis (OR 0.51 [0.31–0.86]) are protective towards EE. This study demonstrates that age, ethnicity, unmarried, long-term GERD, metabolic diseases, HH, and NAFLD act as risk factors for EE, whereas H. pylori infection and atrophic gastritis act as protective factors. These findings may enable a better understanding of EE and increase greater awareness to address its growing burden. |
format | Online Article Text |
id | pubmed-10502104 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-105021042023-09-16 Risk factors and 26-years worldwide prevalence of endoscopic erosive esophagitis from 1997 to 2022: a meta-analysis Witarto, Andro Pramana Witarto, Bendix Samarta Pramudito, Shidi Laras Ratri, Lintang Cahyaning Wairooy, Nabilah Azzah Putri Konstantin, Tiffany Putra, Achmad Januar Er Wungu, Citrawati Dyah Kencono Mufida, Annisa Zahra Gusnanto, Arief Sci Rep Article Erosive esophagitis (EE) is the part of gastroesophageal reflux disease (GERD) spectrum and may progress to esophageal adenocarcinoma. Due to its progressivity and unclear prevalence, we aim to identify the factors contributing in EE to decide the need for further examination. We performed a PRISMA 2020-based systematic search through PubMed and other resources up to June 2, 2022. Study quality was assessed using the Newcastle–Ottawa Scale (NOS). The odds ratio (OR) of each factor and worldwide prevalence of EE were measured. There are 114 observational studies included with a total of 759,100 participants. Out of 29 factors, the significant risk factors are age ≥ 60 y.o. (OR 2.03 [1.81–2.28]), White/Caucasian (OR 1.67 [1.40–1.99]), unmarried (OR 1.08 [1.03–1.14]), having GERD ≥ 5 years (OR 1.27 [1.14–1.42]), general obesity (OR 1.78 [1.61–1.98]), central obesity (OR 1.29 [1.18–1.42]), diabetes mellitus (DM) (OR 1.24 [1.17–1.32]), hypertension (OR 1.16 [1.09–1.23]), dyslipidemia (OR 1.15 [1.06–1.24]), hypertriglyceridemia (OR 1.42 [1.29–1.57]), hiatal hernia (HH) (OR 4.07 [3.21–5.17]), and non-alcoholic fatty liver disease (NAFLD) (OR 1.26 [1.18–1.34]). However, H. pylori infection (OR 0.56 [0.48–0.66]) and atrophic gastritis (OR 0.51 [0.31–0.86]) are protective towards EE. This study demonstrates that age, ethnicity, unmarried, long-term GERD, metabolic diseases, HH, and NAFLD act as risk factors for EE, whereas H. pylori infection and atrophic gastritis act as protective factors. These findings may enable a better understanding of EE and increase greater awareness to address its growing burden. Nature Publishing Group UK 2023-09-14 /pmc/articles/PMC10502104/ /pubmed/37709957 http://dx.doi.org/10.1038/s41598-023-42636-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Witarto, Andro Pramana Witarto, Bendix Samarta Pramudito, Shidi Laras Ratri, Lintang Cahyaning Wairooy, Nabilah Azzah Putri Konstantin, Tiffany Putra, Achmad Januar Er Wungu, Citrawati Dyah Kencono Mufida, Annisa Zahra Gusnanto, Arief Risk factors and 26-years worldwide prevalence of endoscopic erosive esophagitis from 1997 to 2022: a meta-analysis |
title | Risk factors and 26-years worldwide prevalence of endoscopic erosive esophagitis from 1997 to 2022: a meta-analysis |
title_full | Risk factors and 26-years worldwide prevalence of endoscopic erosive esophagitis from 1997 to 2022: a meta-analysis |
title_fullStr | Risk factors and 26-years worldwide prevalence of endoscopic erosive esophagitis from 1997 to 2022: a meta-analysis |
title_full_unstemmed | Risk factors and 26-years worldwide prevalence of endoscopic erosive esophagitis from 1997 to 2022: a meta-analysis |
title_short | Risk factors and 26-years worldwide prevalence of endoscopic erosive esophagitis from 1997 to 2022: a meta-analysis |
title_sort | risk factors and 26-years worldwide prevalence of endoscopic erosive esophagitis from 1997 to 2022: a meta-analysis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502104/ https://www.ncbi.nlm.nih.gov/pubmed/37709957 http://dx.doi.org/10.1038/s41598-023-42636-7 |
work_keys_str_mv | AT witartoandropramana riskfactorsand26yearsworldwideprevalenceofendoscopicerosiveesophagitisfrom1997to2022ametaanalysis AT witartobendixsamarta riskfactorsand26yearsworldwideprevalenceofendoscopicerosiveesophagitisfrom1997to2022ametaanalysis AT pramuditoshidilaras riskfactorsand26yearsworldwideprevalenceofendoscopicerosiveesophagitisfrom1997to2022ametaanalysis AT ratrilintangcahyaning riskfactorsand26yearsworldwideprevalenceofendoscopicerosiveesophagitisfrom1997to2022ametaanalysis AT wairooynabilahazzahputri riskfactorsand26yearsworldwideprevalenceofendoscopicerosiveesophagitisfrom1997to2022ametaanalysis AT konstantintiffany riskfactorsand26yearsworldwideprevalenceofendoscopicerosiveesophagitisfrom1997to2022ametaanalysis AT putraachmadjanuarer riskfactorsand26yearsworldwideprevalenceofendoscopicerosiveesophagitisfrom1997to2022ametaanalysis AT wungucitrawatidyahkencono riskfactorsand26yearsworldwideprevalenceofendoscopicerosiveesophagitisfrom1997to2022ametaanalysis AT mufidaannisazahra riskfactorsand26yearsworldwideprevalenceofendoscopicerosiveesophagitisfrom1997to2022ametaanalysis AT gusnantoarief riskfactorsand26yearsworldwideprevalenceofendoscopicerosiveesophagitisfrom1997to2022ametaanalysis |